For example, results of a recent study indicate that blockade of PD-L1 interaction with B7-1 in trans can augment tumor immunity via down-regulating the effect of PD-L1 interaction with PD-1 that also required CD28-dependent activation (107). The gene discussed is CD80; the disease is neoplasm.